跳至主要内容
临床试验/NCT02113605
NCT02113605已完成不适用

Exposure-Based CBT for Children With Functional Gastrointestinal Disorders - Development of a Protocol

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Change in Faces Pain Rating Scale (FACES) from baseline to 10 weeks

研究概览

简要总结

The purpose of the trial is to develop a treatment protocol to be used in trials studying internet-delivered CBT for children with functional gastrointestinal disorders (FGID). The study size is not based on power calculations but the estimated sample necessary to develop a treatment protocol. This study will include 20-30 children with FGID and their parents who will be treated individually (face-to-face). The treatment consists of 10 weekly sessions of exposure-based CBT. The study uses a pre- post-design with no control group.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
8 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age between 8-12 years
  • A diagnosis of a functional gastrointestinal disorder by a treating physician

排除标准

  • Concurrent serious medical condition or gastrointestinal symptoms likely caused by an organic disorder.
  • Psychiatric disorder more urgent to treat than the abdominal pain.
  • On-going psychological treatment.
  • Absence from school more than 40 %.
  • Ongoing maltreatment, violence or severe parental psychiatric illness.
  • Pronounced language or learning difficulties that hinder the child to benefit from the treatment.

结局指标

主要结局

Change in Faces Pain Rating Scale (FACES) from baseline to 10 weeks

时间窗: Baseline and 10 weeks

Change in Faces Pain Rating Scale (FACES) from baseline to 8 months.

时间窗: Baseline and 8 months.

次要结局

  • Change in Gastrointestinal Symptom Scale (PedsQL Gastro) from baseline to 10 weeks(Baseline and 10 weeks.)
  • Change in Pain Reactivity Scale from baseline to 10 weeks.(Baseline and 10 weeks.)
  • Change in Child Depression Inventory (CDI) from baseline to 10 weeks.(Baseline and 10 weeks.)
  • Change in Pain Interference Index (PII) from baseline to 10 weeks.(Baseline and 10 weeks.)
  • Change in Children´s Somatization Inventory (CSI 24) from baseline to 8 months(Baseline and 8 months.)
  • Change in Spence Children Anxiety Scale (SCAS) from baseline to 10 weeks.(Baseline and 10 weeks.)
  • Change in Gastrointestinal Symptom Rating Scale (GSRS-IBS) from baseline to 8 months.(Baseline and 8 months)
  • Change in Pain Interference Index (PII) from baseline to 8 months.(Baseline and 8 months.)
  • Change in Children´s Somatization Inventory (CSI 24) from baseline to 10 weeks(Baseline and 10 weeks.)
  • Change in Functional Disability Index (FDI) from baseline to 10 weeks.(Baseline and 10 weeks.)
  • Change in Pediatric Quality of Life Inventory (Peds QL) from baseline to 8 months.(Baseline and 8 months.)
  • Change in Gastrointestinal Symptom Scale (PedsQL Gastro) from baseline to 8 months.(Baseline and 8 months.)
  • Change in Functional Disability Index (FDI) from baseline to 8 months.(Baseline and 8 months.)
  • Change in IBS-behavioral responses questionnaires (IBS-BRQ) from baseline to 8 months.(Baseline and 8 months.)
  • Change in Spence Children Anxiety Scale (SCAS) from baseline to 8 months.(Baseline and 8 months.)
  • Change in Child Depression Inventory (CDI) from baseline to 8 months.(Baseline and 8 months.)
  • Change in Gastrointestinal Symptom Rating Scale (GSRS-IBS) from baseline to 10 weeks.(Baseline and 10 weeks.)
  • Change in IBS-behavioral responses questionnaires (IBS-BRQ) from baseline to 10 weeks.(Baseline and 10 weeks.)
  • Change in Pediatric Quality of Life Inventory (Peds QL) from baseline to 10 weeks.(Baseline and 10 weeks.)
  • Change in Pain Reactivity Scale from baseline to 8 months.(Baseline and 8 months.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ola Olen

MD, PhD

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验